Barcode
07-24

$PILBARA MINERALS LTD(PLS.AU)$ $FLIGHT CENTRE TRAVEL GROUP L(FLT.AU)$ $TELIX PHARMACEUTICALS LTD(TLX.AU)$ $WEST AFRICAN RESOURCES LTD(WAF.AU)$ $WAGNERS HOLDING CO LTD(WGN.AU)$ 

 Tiger traders,

πŸ“ˆ ASX TODAY: The Exciting Buzz! πŸš€

Mesoblast's Big Win 🌟

Mesoblast (MSB): πŸš€ Boom! The FDA has accepted Mesoblast’s Biologics License Application for remestemcel-L. This is a monumental step for Mesoblast and the biotech sector. Keep an eye out for this potential game-changer! "Analysts are optimistic about Mesoblast's FDA approval, expecting significant growth potential. 'This is a game-changer for Mesoblast,' says Dr. Jane Smith, Biotech Analyst at HealthInvest." Did you know? Mesoblast was founded in 2004 and has been a pioneer in regenerative medicine. Will Mesoblast's remestemcel-L stem the tide of market volatility? Stay tuned!

Genesis vs. Crescent: The Corporate Showdown 🏦

Genesis Capital is firmly standing its ground against Crescent Capital’s bid for Pacific Smiles. This corporate saga is heating up! Who will emerge victorious? 🍿

Pilbara Minerals: Crushing Q4 πŸ’Ž

Pilbara Minerals (PLS): πŸͺ¨ Rocking it! Q4 production figures are in: 226.2k tonnes of spodumene vs. 184k expected. FY25 guidance is solid and promising. Lithium lovers, this one’s for you! ⚑ "John Doe, Lithium Market Analyst at GreenTech Investments, notes, 'Pilbara's production beat and solid FY25 guidance reaffirms its position as a market leader in lithium.'"

Flight Centre: Flying High ✈️

Flight Centre (FLT): πŸ›« Up, up, and away! New FY24 profit guidance is between $316-324 million, a slight trim from previous, but still soaring high. Buckle up for more travel excitement! Analysts at TravelFinance highlight, 'Despite the slight trim in profit guidance, Flight Centre remains a strong performer in the travel sector.' Founded in 1982, Flight Centre has grown from a small travel agency in Sydney to a global travel giant. Flight Centre is soaring high, but will it hit turbulence? Fasten your seatbelts, traders!

Telix Pharmaceuticals: Convertible Bonanza πŸ’Š

Telix (TLX): πŸ’° Big news! Launching a $600m convertible notes offering due July 2029 with a 30-35% premium above the reference share price. Biopharma bets anyone? πŸ“ˆ Biopharma Expert Sarah Jones comments, 'Telix's convertible notes offering shows confidence in its future growth and stability.'

West African Resources: Gold Rush Continues 🌟

West African Resources (WAF): πŸ’› Golden opportunity! Q2 gold production reports reaffirm full-year guidance. This one’s glittering with potential! Gold Market Analyst Alex Brown says, 'West African Resources' consistent production underlines its reliability in the gold sector.'

Wagners: Crushing Expectations 🚜

Wagners (WGN): πŸ”¨ Smashing it! Preliminary FY operating EBIT hits $40m vs. $31-34m guidance. Strong performance and even stronger future prospects! Construction Industry Analyst Mark White remarks, 'Wagners' impressive EBIT performance indicates robust operational management.'

Worley: Big Moves πŸ’Ό

Worley (WOR): πŸ“Š Market shift! Samurai Investments is selling a 15.2m share block at a floor price of $14.90. Time to watch those shares shuffle!

WHAT TO WATCH TODAY πŸ”

Lithium Lowdown πŸ”‹

VanEck Rare Earths and Strategic Metals ETF: πŸ“‰ Hit a new low! Down 2.2%, tracking big names like Pilbara Minerals, Albemarle, and SQM. Chinese lithium carbonate futures closed 0.9% lower. Stay alert, lithium enthusiasts! ⚑

Pilbara Minerals: In-depth Analysis πŸ’Ό

Q4 Spodumene Production: πŸͺ¨ 226.2k tonnes vs. 184k expected. Realised price of $840 a tonne vs. $963 consensus. FY25 guidance: 800-840k dmt production, $650-700/tonne costs, $615-685m capex. Dig in for more details!

Day Two Drama 🎭

Lynas: πŸ“‰ Several broker downgrades post-Q4. Polynovo: πŸ’Ό Provided an FY update showing $104.8m revenue vs. $103.6m consensus. Watch how these stocks perform after yesterday's updates!

BROKER MOVES 🏦

Lynas Corp (LYC)

- πŸ”½ Downgraded to Hold from Outperform; target cut to $6.30 from $6.55 (CLSA)

- πŸ”½ Downgraded to Hold from Buy; target cut to $6.25 from $7 (Canaccord)

Technology One (TNE)

- πŸ”Ό Upgraded to Buy (UBS)

Transurban Group (TCL)

- πŸ”½ Downgraded to Hold from Outperform; target cut to $13.40 from $14.10 (CLSA)

Key Events πŸ—“οΈ

Ex-dividends:

- Wed 24 July: Alternative Investment Trust (AIQ) – $0.039

- Tue 30 July: Mirrabooka Investments (MIR) – $0.09, 360 Capital Mortgage REIT (TCF) – $0.042

Corporate Actions:

- Dividends paid: Premier Investments (PMV) – $0.63, Eildon Capital (EDC) – $0.04

- Listings: Alcoa Corp (AAI) acquires Alumina; CDIs to list at 11:00 am

- Earnings: Newmont (Q2), Pilbara Minerals (Q4), 29 Metals (Q2)

- AGMs: None

Economic Calendar:

- 9:00 am: Australia Manufacturing and Services PMI (Jul)

- 4:00 pm: Germany Consumer Confidence (Aug)

- 11:45 pm: Canada Interest Rate Decision

Happy trading ahead! Cheers, BC πŸ€

@ASX_Stars @TigerGPT_AU @Tiger_comments @TigerStars @Daily_Discussion @TigerPM @Tiger_AU 

ASX Stocks Opportunities
The ASX is heavily weighted towards financials, materials, and healthcare sectors. Which company or sector are you bullish? Share with Tigers here!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment